Background: Complications of ileoanal pouch surgery affecting function and quality of life may require surgical correction or pouch excision. The management of patients with pouch dysfunction requires a multidisciplinary approach and demand for service provisions include multiple healthcare professionals and resources. The aim of this study is to present the service requirements, surgical outcomes for redo pouch surgery and pouch excision, with cost-analysis of the required resources. Methods: All patients undergoing surgery for revision or excision of the ileoanal pouch from June 2021 to May 2023 were prospectively included. Patient undergoing only diagnostic procedures, or perineal procedures were excluded. Outcomes within 30-days of surgery were collected, including readmissions and re-operations. Cost analysis of all investigations, outpatient appointments and procedures prior to pouch revision or pouch excision was conducted. Results: Twenty patients were included during the 24 months study period: 13 underwent abdominal revisional pouch surgery, 7 had ileoanal pouch excision. 15 patients (75%) were tertiary referrals from other hospitals in the UK. The median interval between index IPAA surgery and revision was 113 months. 3 multidisciplinary clinical appointments, 2 imaging modalities, and at least one invasive day-surgery procedure were required for each patient prior to surgery. Four patients (20%) developed Clavien-Dindo 3 or higher complications. Conclusions: We estimated a starting cost of £22.605 ($29.589) for provision of pouch revision or excision surgery for investigations and treatments from referral to the pouch unit to surgery. Expertise and infrastructure are needed for indication and peri-operative management of these uncommonly performed surgical procedures.
Methods used in cost calculation have a profound effect on cost-effectiveness analyses, thereby influencing UK healthcare decision-making. The aim of this study was to quantify the impact of different cost assessments using data obtained alongside a recent randomised clinical trial (RCT) on endovenous treatments for varicose veins. National reimbursement data from payment by results (PbR) were compared to the service line report (SLR) and RCT micro-costing data. There were 18 laser and 205 foam treated patients from the 2010–2011 day-case activity SLR. There were 100 RCT patients which were separated for costing into session treatments (2 laser, 3 tumescent foam or 5 standard foam treatments per 3.5 hour session) as well as individually-timed treatments. Reimbursement was £1098, irrespective of treatment type. Using SLR derived data the cost of laser, tumescent foam and standard foam per patient was £1059, £603 and £551, respectively. This decreased to £812, £239 and £124 using session calculations and decreased further to a median (inter-quartile range) of £721 (677–774), £195 (176–209) and £100 (93–109) using individually timed treatments (P < 0.0005, Kruskal-Wallis). Cost differences between laser and foam increase significantly using micro-costing. Several costing approaches may be required for representative cost-effectiveness comparisons.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.